Pleasant Hill, CA, United States of America

Albert Boosman

This inventor holds 1 USPTO granted patent. Top assignees: Albert Einstein College of Medicine, Chiron Corporation. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Albert Boosman: Innovator in Protein Purification

Introduction

Albert Boosman is a notable inventor based in Pleasant Hill, CA (US). He has made significant contributions to the field of protein purification, particularly through his work on colony stimulating factor-1 (CSF-1). His innovative approach has led to advancements in the purification and sequencing of important proteins.

Latest Patents

Albert Boosman holds a patent for "Purified human CSF-1." This invention relates to the purification of proteins, the products of such purification, and the DNA probes constructed from them. More specifically, it focuses on the purification and sequencing of murine and human colony stimulating factor-1 (CSF-1). He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Albert Boosman has worked with prominent organizations such as Chiron Corporation and the Albert Einstein College of Medicine. His experience in these institutions has allowed him to collaborate with leading experts in the field of biomedical research.

Collaborations

Some of his notable coworkers include Mary Kim Warren and Judit Csejtey. Their collaborative efforts have contributed to the advancement of research in protein purification and related fields.

Conclusion

Albert Boosman is a distinguished inventor whose work in protein purification has had a lasting impact on the scientific community. His contributions continue to influence research and innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…